Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The Multi-Faceted Consequences of NRF2 Activation throughout Carcinogenesis.
Mol Cells. 2023 Mar 31;46(3):176-186. doi: 10.14348/molcells.2023.2191. Epub 2023 Mar 22.
Mol Cells. 2023.
PMID: 36994476
Free PMC article.
Review.
Potential therapeutic uses of rexinoids.
Leal AS, Reich LA, Moerland JA, Zhang D, Liby KT.
Leal AS, et al. Among authors: moerland ja.
Adv Pharmacol. 2021;91:141-183. doi: 10.1016/bs.apha.2021.01.004. Epub 2021 Mar 4.
Adv Pharmacol. 2021.
PMID: 34099107
Review.
Item in Clipboard
The Triterpenoid CDDO-Methyl Ester Redirects Macrophage Polarization and Reduces Lung Tumor Burden in a Nrf2-Dependent Manner.
Moerland JA, Leal AS, Lockwood B, Demireva EY, Xie H, Krieger-Burke T, Liby KT.
Moerland JA, et al.
Antioxidants (Basel). 2023 Jan 3;12(1):116. doi: 10.3390/antiox12010116.
Antioxidants (Basel). 2023.
PMID: 36670978
Free PMC article.
Item in Clipboard
The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer.
Reich LA, Moerland JA, Leal AS, Zhang D, Carapellucci S, Lockwood B, Jurutka PW, Marshall PA, Wagner CE, Liby KT.
Reich LA, et al. Among authors: moerland ja.
Sci Rep. 2022 Jan 7;12(1):293. doi: 10.1038/s41598-021-04415-0.
Sci Rep. 2022.
PMID: 34997154
Free PMC article.
Item in Clipboard
The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer.
Moerland JA, Zhang D, Reich LA, Carapellucci S, Lockwood B, Leal AS, Krieger-Burke T, Aleiwi B, Ellsworth E, Liby KT.
Moerland JA, et al.
Sci Rep. 2020 Dec 17;10(1):22244. doi: 10.1038/s41598-020-79260-8.
Sci Rep. 2020.
PMID: 33335263
Free PMC article.
Item in Clipboard
The RXR Agonist MSU42011 Is Effective for the Treatment of Preclinical HER2+ Breast Cancer and Kras-Driven Lung Cancer.
Leal AS, Moerland JA, Zhang D, Carapellucci S, Lockwood B, Krieger-Burke T, Aleiwi B, Ellsworth E, Liby KT.
Leal AS, et al. Among authors: moerland ja.
Cancers (Basel). 2021 Oct 6;13(19):5004. doi: 10.3390/cancers13195004.
Cancers (Basel). 2021.
PMID: 34638488
Free PMC article.
Item in Clipboard
Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models.
Leal AS, Zydeck K, Carapellucci S, Reich LA, Zhang D, Moerland JA, Sporn MB, Liby KT.
Leal AS, et al. Among authors: moerland ja.
NPJ Breast Cancer. 2019 Nov 1;5:39. doi: 10.1038/s41523-019-0135-5. eCollection 2019.
NPJ Breast Cancer. 2019.
PMID: 31700995
Free PMC article.
Item in Clipboard
Cite
Cite